Though we are progressing well against our commitments, we are mindful that our work continues for many more years to come. We are energized to tackle the challenges ahead, and hope to share this enthusiasm beyond our own teams to inspire people across our industry to join us in our mission to transform patients’ lives through science.
Reflecting on the first anniversary of our BMS Commitments in diversity, inclusion and health equity
By Ann Powell, Chief Human Resources Officer
At this time last year, our company, along with the Bristol Myers Squibb Foundation, proudly announced five bold commitments to help address disparities in healthcare, increase diversity in clinical trials, expand the supply chain to include more diverse suppliers, enhance our employees’ ability to give back to the community, and increase the diversity of our own workforce.
For me personally, the commitments we made represent everything that Bristol Myers Squibb stands for in advancing health for people of all backgrounds and communities. When I talk to colleagues about our efforts in these areas, they use words like proud, courageous, hopeful, accountable, motivated. Those words speak to our culture of both innovation and inclusion – an entire community with a shared mindset to serve patients.
Over the past year, teams across our organization have coalesced to dismantle some of the toughest challenges in our industry in diversity, inclusion and health equity.
And while we don’t have all the answers, we are making progress:
This week, we announced a partnership with historically black colleges and universities to create and sustain a pipeline of diverse talent. We also released the In This Together: Our Commitment to Global Diversity and Inclusion report, which highlights our transformative business model and goals for our people and culture.
$11.1 million in Corporate Giving grants were awarded to 56 non-profit organizations across the United States. These grants will improve access to high-quality care and increase disease awareness and education for medically underserved communities.
Our supplier partners provide our company with diverse points of view and knowledge transfer. With our goal to spend $1 billion with diverse suppliers around the world over the next 5 years, by Partnering with Purpose we will help expand capacity in diverse businesses, create jobs, lift communities and drive supply chain innovation. We are on our way to meeting that goal while building trust and supplying change.
Clinical trial diversity
Our teams are working tirelessly to increase diversity in clinical trials. In the near term, we will locate 25 percent of U.S. clinical trial research sites in highly diverse communities by 2022, which we believe will lead to better science and patient outcomes. Additionally, the Bristol Myers Squibb Foundation opened applications for its Diversity in Clinical Trials Career Development Program in partnership with National Medical Fellowships to train 250 diverse clinical trial investigators and training begins later this year.
We have a robust employee giving program, and the social unrest in the US inspired our People and Business Resource Groups (PBRGs) to identify social justice organizations fighting disparities and discrimination for a 2-to-1 match. To date, more than a thousand of our colleagues in the U.S. and Puerto Rico have donated, with participation growing.